医疗设备的流通交易:2016年～2025年

《医疗器材分销交易》深入了解并分析了公司如何以及为何达成分销交易。本报告提供了2016年至2025年的详细分销协议。

此报告提供双方宣布的分销交易的付款条款。这些数据为付款条款和其他贸易条款提供了宝贵的见解。

了解潜在合作伙伴谈判的交易条款的灵活性可以为谈判过程提供重要的见解，让您了解在谈判条款时会发生什么。许多中小企业可能会要求详细的付款条款，但当涉及如何触发付款和权利转移时，细节决定成败。这种见解在新闻稿或资料库中找不到，而是来自合约文件。

本报告提供了当前协议交易和合作伙伴关係资料库中记录的自 2016 年以来宣布的分销交易的综合列表，包括可用的财务条款，并提供了公司及其合作伙伴向 SEC 提交的实际分销协议文件的在线副本链接。

报告的第一部分涵盖分销贸易和商业活动。

第 1 章对报告进行了介绍，第 2 章概述并分析了分销趋势，并讨论了交易类型的好处。

第 3 章概述了分销协议的结构。

第 4 章回顾了 2016 年以来的主要分销交易。交易按标题价值列出。如果交易与美国证券交易委员会 (SEC) 发布了协议，则该连结可透过当前协议交易和联盟资料库在线存取该协议。

第 5 章提供了最活跃的 25 家经销商的综合清单。每个交易标题都透过当前协议交易和联盟资料库连结到完整交易记录的线上版本，并在可用时连结到实际合约文件，从而允许轻鬆、按需存取每个交易记录。

交易目录包含自 2016 年以来宣布的所有分销交易的综合清单。每个清单都按公司 A-Z、治疗领域和技术类型组织成交易目录。每个交易标题透过超连结连结到交易记录的线上版本，包括实际的合约文件。

该报告还包含大量图表和图形，展示了自 2016 年以来分销交易的趋势和活动。

目录

摘要整理

第1章 简介

第2章 流通交易趋势

• 简介
• 流通交易定义
• 2016年以后的流通交易趋势
  • 流通交易的各年度转变，2016年～2025年
  • 各开发阶段的流通交易，2016年～2025年
  • 各治疗领域的流通交易，2016年～2025年
  • 各技术类型的流通交易，2016年～2025年
  • 最活跃的各企业流通交易，2016年～2025年
• 签订流通联盟契约的理由

第3章 -流通交易结构概要

• 简介
• 流通交易结构

第4章 -主要流通交易

• 简介
• 主要的流通交易，各金额

第5章 -最活跃的流通交易业者主要25公司

• 简介
• 25 家最活跃的经销商
• 交易名录
• 交易名录- 各企业流通交易一览(AZ)
• 交易名录- 各治疗领域的流通交易
• 交易名录- 各技术类型的流通交易
• 关于调查公司
• 目前联盟
• 目前契约
• Current Partnering的最近的报告标题

Distribution Deals in Medical Devices provides a detailed understanding and analysis of how and why companies enter distribution deals.

Fully revised and updated, the report provides details of distribution deals from 2016 to 2025.

The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of distribution deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in distribution as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of distribution deals.

Chapter 4 provides a review of the leading distribution deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active distribution dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

The deal directory includes a comprehensive listing of all distribution deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in distribution dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about distribution alliances.

Key benefits

Distribution Deals in Medical Devices provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse distribution deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Distribution Deals in Medical Devices is intended to provide the reader with an in-depth understanding of the distribution trends and structure of deals entered into by leading biopharma companies worldwide.

Distribution Deals in Medical Devices includes:

• Trends in distribution dealmaking in the biopharma industry
• Overview of distribution deal structure
• Directory of distribution deal records covering medical devices
• The leading distribution deals by value
• Most active distribution dealmakers
• The leading distribution partnering resources

In Distribution Deals in Medical Devices, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Distribution Deals in Medical Devices provides comprehensive access to available records for distribution deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals since 2016
  • 2.3.1. Distribution dealmaking by year, 2016-2025
  • 2.3.2. Distribution dealmaking by phase of development, 2016-2025
  • 2.3.3. Distribution dealmaking by therapy area, 2016-2025
  • 2.3.4. Distribution dealmaking by technology type, 2016-2025
  • 2.3.5. Distribution dealmaking by most active company, 2016-2025
• 2.4. Reasons for entering into distribution partnering deals

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements, 2016 to 2025
• Figure 3: Distribution deals signed at each phase of development, 2016 to 2025
• Figure 4: Distribution deals by therapy area, 2016 to 2025
• Figure 5: Distribution deals by technology type, 2016 to 2025
• Figure 6: Top 25 most active distribution dealmakers, 2016 to 2025
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value 2016 to 2025
• Figure 11: Most active distribution dealmakers 2016 to 2025